# Civil Money Penalties Relating to the ClinicalTrialsgov Data Bank:  Guidance for Responsible Parties, Submitters of Certain Applications and Submissions to FDA, and FDA Staff - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/civil-money-penalties-relating-to-the-clinicaltrialsgov-data-bank-guidance-for-responsible-parties-submitters-of-certain-applications-and-submissions-to-fda-and-fda-staff/0e9dc583-3ef6-4205-9302-de301840b935

> FDA guidance document: Civil Money Penalties Relating to the ClinicalTrialsgov Data Bank:  Guidance for Responsible Parties, Submitters of Certain Applications and Submissions to FDA, and FDA Staff. Issue date: August 14, 2020. Get complete insights and analysis.

---

## Details

- Title: Civil Money Penalties Relating to the ClinicalTrialsgov Data Bank:  Guidance for Responsible Parties, Submitters of Certain Applications and Submissions to FDA, and FDA Staff
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2020-08-14
- Last Changed: 2024-11-05
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-0787">FDA-2018-D-0787</a>

## Related Documents

- [Current Good Manufacturing Practice Requirements for Combination Products:  Guidance for Industry and FDA Staff](https://www.globalkeysolutions.net/guidances/guidance-document/current-good-manufacturing-practice-requirements-for-combination-products-guidance-for-industry-and-fda-staff/ace9180c-ec42-40e7-9c00-fc09b45ecbc3)
- [Evaluation of Sex Differences in Clinical Investigations:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/information-sheet/evaluation-of-sex-differences-in-clinical-investigations-guidance-for-industry/92c2b117-2251-40a9-9086-3ebfed65505e)
- [Adverse Event Reporting to IRBs — Improving Human Subject Protection:  Guidance for Clinical Investigators, Sponsors, and IRBs](https://www.globalkeysolutions.net/guidances/guidance-document/adverse-event-reporting-to-irbs-improving-human-subject-protection-guidance-for-clinical-investigators-sponsors-and-irbs/8b4e7049-16fc-40f8-b121-81ece765bc26)